We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-14.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$69.6B
AUM Growth
-$16.5B
(-19%)
Cap. Flow
-$3.3B
Cap. Flow
% of AUM
-4.75%
Top 10 Holdings %
Top 10 Hldgs %
17.71%
Holding
779
New
83
Increased
294
Reduced
313
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$753M |
| 2 |
Marathon Petroleum
MPC
|
+$374M |
| 3 |
Target
TGT
|
+$361M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$299M |
| 5 |
Huntington Bancshares
HBAN
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANDV
Andeavor
ANDV
|
+$1.05B |
| 2 |
Merck
MRK
|
+$702M |
| 3 |
Bank of America
BAC
|
+$542M |
| 4 |
Oracle
ORCL
|
+$528M |
| 5 |
Steel Dynamics
STLD
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.74% |
| 2 | Healthcare | 14.95% |
| 3 | Industrials | 13.38% |
| 4 | Technology | 12.24% |
| 5 | Energy | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRSU
476
Pursuit Attractions and Hospitality Inc
PRSU
$1.36B
| $3.06M | ﹤0.01% |
61,048
+1,202
| +2% | +$61.2K |
|
477
CACI
CACI
$13.9B
| $2.98M | ﹤0.01% |
20,722
+16,801
| +428% | +$2.86M |
|
|
ETRN
478
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $2.98M | ﹤0.01% |
+148,756
| New | +$3.14M |
|
479
Fulton Financial
FULT
$4.52B
| $2.95M | ﹤0.01% |
190,470
-67,090
| -26% | -$1.09M |
|
|
STFC
480
DELISTED
State Auto Financial Corp
STFC
| $2.95M | ﹤0.01% |
86,544
+1,409
| +2% | +$45.9K |
|
481
Stewart Information Services
STC
$2.13B
| $2.93M | ﹤0.01% |
70,812
+1,288
| +2% | +$54.1K |
|
482
QuinStreet
QNST
$1.09B
| $2.91M | ﹤0.01% |
+179,358
| New | +$2.7M |
|
483
InterDigital
IDCC
$8.65B
| $2.9M | ﹤0.01% |
43,725
-16,970
| -28% | -$1.24M |
|
|
GHL
484
DELISTED
Greenhill & Co., Inc.
GHL
| $2.89M | ﹤0.01% |
118,453
+2,327
| +2% | +$56.9K |
|
485
Exelon
EXC
$45.3B
| $2.88M | ﹤0.01% |
89,612
+606
| +0.7% | +$19.4K |
|
486
VeriSign
VRSN
$26.4B
| $2.88M | ﹤0.01% |
19,420
-6,301
| -24% | -$945K |
|
|
IOTS
487
DELISTED
Adesto Technologies Corp
IOTS
| $2.88M | ﹤0.01% |
654,400
+349,900
| +115% | +$1.67M |
|
488
Coca-Cola
KO
$386B
| $2.87M | ﹤0.01% |
60,693
-32,557
| -35% | -$1.56M |
|
|
SAVE
489
DELISTED
Spirit Airlines, Inc.
SAVE
| $2.86M | ﹤0.01% |
49,360
-55,100
| -53% | -$2.95M |
|
490
Jacobs Solutions
J
$17.8B
| $2.84M | ﹤0.01% |
58,775
-19,274
| -25% | -$1.1M |
|
491
U-Haul Holding Co
UHAL
$13.3B
| $2.84M | ﹤0.01% |
86,420
-6,590
| -7% | -$223K |
|
|
QADA
492
DELISTED
QAD Inc.
QADA
| $2.78M | ﹤0.01% |
70,610
-14,200
| -17% | -$621K |
|
|
APC
493
DELISTED
Anadarko Petroleum
APC
| $2.75M | ﹤0.01% |
62,785
-3,568,014
| -98% | -$201M |
|
494
Arthur J. Gallagher & Co
AJG
$68.6B
| $2.75M | ﹤0.01% |
37,280
-17,542
| -32% | -$1.31M |
|
495
POSCO
PKX
$18.2B
| $2.75M | ﹤0.01% |
50,000
+30,000
| +150% | +$1.72M |
|
496
DMC Global
BOOM
$141M
| $2.74M | ﹤0.01% |
78,103
-18,468
| -19% | -$671K |
|
497
Teva Pharmaceuticals
TEVA
$42.5B
| $2.72M | ﹤0.01% |
+176,478
| New | +$3.62M |
|
498
Philip Morris
PM
$299B
| $2.72M | ﹤0.01% |
40,699
-167,805
| -80% | -$14M |
|
499
Argan
AGX
$5.86B
| $2.72M | ﹤0.01% |
71,779
-27,952
| -28% | -$1.18M |
|
500
Fabrinet
FN
$14.8B
| $2.69M | ﹤0.01% |
+52,373
| New | +$2.51M |
|
Similar funds
Boston Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Boston Partners held 779 positions worth $69.6B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners withdrew a net $3.3B in Q4 2018, closing 76 positions and reducing 313 holdings. Its most notable exit was Andeavor, an estimated $1.05B position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Boston Partners opened a new position in Procter & Gamble worth $775M.
- Boston Partners's largest Q4 2018 buy was Procter & Gamble: 8,428,522 shares worth $775M.
- Boston Partners added most to Marathon Petroleum in Q4 2018, an estimated $374M increase.
- Boston Partners's biggest Q4 2018 reduction was Merck, cutting an estimated $702M.
- Boston Partners fully exited Andeavor in Q4 2018, selling an estimated $1.05B.
- Boston Partners's ten largest holdings make up 18% of its $69.6B portfolio in Q4 2018.
- Boston Partners opened 83 new positions and closed 76 in Q4 2018.
- Boston Partners's portfolio value fell 19% quarter-over-quarter to $69.6B.
Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.